Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sprint interval exercise disrupts mitochondrial ultrastructure driving a unique mitochondrial stress response and remodelling in men.

Nature communications·2025

Same author

Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intention.

Journal of tissue viability·2025

Same author

Limited Empirical Support for Relative Energy Deficiency in Sport (REDs) Syndrome.

Sports medicine (Auckland, N.Z.)·2025

Same author

Quasi-periodic X-ray eruptions years after a nearby tidal disruption event.

Nature·2024

Same author

A multi-organ map of the human immune system across age, sex and ethnicity.

bioRxiv : the preprint server for biology·2024

Same author

Outcomes following supervised exercise and home-based exercise for patients with intermittent claudication.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·2022

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes.

S E Hussey, S L McGee, A Garnham

Diabetes, Obesity & Metabolism

|May 28, 2011

Summary

Exercise training boosts glucose transporter type 4 (GLUT4) expression in adipose tissue and skeletal muscle for type 2 diabetes (T2D) patients. This adaptation improves glucose uptake, but optimal benefits depend on pancreatic beta-cell function.

More Related Videos

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

Related Experiment Videos

Last Updated: Jun 1, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

Area of Science:

Endocrinology
Metabolic Research
Exercise Physiology

Background:

Type 2 diabetes (T2D) is characterized by impaired glucose metabolism.
Reduced glucose transporter type 4 (GLUT4) expression in adipose tissue is observed in T2D.
The impact of exercise on GLUT4 expression in T2D requires further elucidation.

Discussion:

Exercise training significantly increased adipose tissue GLUT4 protein expression by 36% in T2D patients.
Skeletal muscle GLUT4 protein expression also rose by 20% following exercise intervention.
These findings highlight exercise as a potential therapeutic strategy for improving glucose homeostasis in T2D.

Key Insights:

Exercise intervention effectively upregulates GLUT4 expression in both adipose and skeletal muscle tissues in individuals with type 2 diabetes.
Adipose tissue GLUT4 expression was significantly lower in T2D patients compared to controls before training.
Skeletal muscle GLUT4 expression did not differ between groups initially but increased with exercise.

Outlook:

Further research is needed to explore the functional consequences of increased GLUT4 expression on insulin sensitivity.
Investigating the role of beta-cell function in mediating the benefits of exercise-induced GLUT4 changes is crucial.
Long-term studies are warranted to assess the sustained impact of exercise on glucose control in T2D.